CEACAM5 and breast cancer: Chen et al. (2020b) compared the sensitivities and specificities of single tests: CEA, CA 15–3, CA125 (SN 4.89%, SP 95.02%) and tumour abnormal protein (TAP) (SN 4.89%, SP 99.62%), and in combinations for the detection of BC.